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Primary tumors in the autochthonous host and tumors transplanted into syngeneic 
recipients usually grow progressively despite the presence of detectable  immunity to 
tumor-associated  antigens.  Several mechanisms  have been suggested  to explain  this 
"escape" from immunological protection (1). Immunological enhancement by humoral 
antibodies is thought to be one of the major factors in the growth of antigenic tumors 
(1, 2).  Most studies  have emphasized  the role of peripheral  forms of inhibition.  In 
afferent  enhancement,  antibodies  bound to the tumor cells interfere  with immuno- 
genicity  (3). In efferent enhancement,  antibodies bound to antigenic sites protect the 
tumor from immunologic attack (2, 4, 5). There has been relatively little experimental 
evidence to support the central form  of enhancement,  in which  immunological re- 
activity of sensitized cells is suppressed (6, 7). The relative in vivo roles of each of these 
mechanisms remains unclear. 
Several in vitro studies  of cell-mediated  immunity have been performed  to define 
the nature of the interference with immunological attack against tumor cells. As in the 
in vivo studies, most of the evidence pointed to a peripheral block (2, 8). 
In plevious studies  (9,  10), we found that cellular immunity to a syngeneic 
Gross  virus-induced  lymphoma in  W/Fu  rats  reached  a  peak  at  9-10  days 
after tumor cell inoculation and then became undetectable after 20 days. The 
tumors themselves usually reached maximum size at 8-14 days and then com- 
pletely regressed. The decrease in cellular reactivity occurred as the levels of 
7S cytotoxic antibody rose (11).  The question of antibody-mediated suppres- 
sion of the cellular immune response was therefore raised.  The present study 
was performed to determine whether there was some form of inhibition of the 
immune cell  population,  after it became unreactive in the direct cytotoxicity 
assays.  Lymphocytes were placed under  a  variety of conditions in  vitro,  to 
determine if they could be reactivated to have cytotoxic effects against Gross 
tumor cells.  Incubation of the directly unreactive immune cells  for  12 hr  or 
more at 37°C, in the absence of added antigen, was found to result in the ap- 
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pearance  of  significant  specific  reactivity.  Experiments  were  then  undertaken 
to define the mechanism  of this in vitro activation. 
Materials and Methods 
Animals.--Inbred,  W/Fu strain, male rats were obtained from the Mammalian Genetics 
and Animal Production Section, National Cancer Institute, Bethesda, Md. 
Tumors.--The  W/Fu rat lymphoma  (C58NT)D  (11), induced by  Gross leukemia virus, 
was maintained in ascites form by serial intraperitoneal passage in weanling W/Fu rats. The 
sources and characteristics of the other tumors, used as  specificity controls, have been de- 
scribed (12). 
Immunization.--1  X  10  s  (C58NT)D  tumor cells,  suspended in saline, were injected sub- 
cutaneously in the right flank of 8-10-wk old W/Fu rats. 
Harvesting  of Lymphoid Cells.--(a) Spleens and lymph nodes were removed from normal or 
immunized rats and finely minced with scalpels in a few milliliters of balanced salt solution 
(BSS) i (Media Production Unit, National Institutes of Health, Bethesda, Md.) supplemented 
with 20cJo heat-inactivated (56°C, 30 rain) fetal bovine serum (FBS) (Grand Island Biological 
Co., Grand Island, N. Y.). The resultant single-cell suspensions were filtered by one passage 
through a  cotton gauze sponge.  (b)  Peripheral blood was obtained by percutaneous cardiac 
puncture and mixed with heparin, 20 units/ml. Most of tile erythrocytes were sedimented by 
adding 1 ml of plasmagel (Laboratoire Roger Bellon, Neuilly, France) per 3 ml of blood and 
incubating the mixture for 30 rain at 37°C. The leukocyte-rich supernatant was then harvested. 
(c) Bone marrow was obtained from the femurs by rinsing of the marrow cavities with approx- 
imately 2 ml of BSS-FBS. The resultant single-cell suspensions were filtered through cotton 
gauze. (d) Peritoneal cells were obtained by introduction of 10-20 ml of BSS into the peritoneal 
cavity and then aspiration with a  multiperforated  16-gauge  troear needle. Each of the cell 
suspensions was washed twice in 50 ml of BSS-FBS and then diluted to the final desired viable 
concentration in tissue culture medium, Eagle's minimal essential medium (Media Production 
Unit, National Institutes of Health) supplemented with 20% heat-inactivated FBS. Viability 
of all cell suspensions by trypan blue dye exclusion was 85-95%. In the direct cytotoxic assays, 
the ceils were immediately tested for cytotoxic reactivity without any preincubafion in vitro. 
Purification of Lymphoid  Cells.--Two methods were used to isolate the lymphocytes from 
the peripheral blood and from the lymphoid organs. 
(a) Nylon column:  2 g of washed nylon (from a Fenwal Leukopak; Fenwal Labs., Morton 
Grove, Ill.) were packed into a  12 ml syringe. The column was first rinsed with warm (37°C) 
BSS-FBS. The cell suspension, at 1 X  107 cells/ml, was then passed through the column, at a 
flow rate of approximately 1-2 drops/sec. 
(b)  Ficoll-Hypaque  gradient:  Cell  suspensions,  at  1  X  107  cells/ml,  were separated as 
described by Boyum (13). The top layer, containing the lymphocytes, was then washed twice 
in 50 ml of BSS-FBS. 
Aasay for Cell-Mediated  Cytoxlcity.--The assay was performed as previously described (9). 
The target cells,  (C58NT)D,  were harvested from the peritoneal cavity of weanling W/Fu 
rats.  The  cell suspension was adjusted to  1-2  X  107 cells/ml.  1 ml of this suspension was 
incubated with 150/~Ci/ml 51Cr (Radiochemical Center, Amersham, England) at 37°C  and 
gently agitated for 30-40 min. For each experimental group, quadruplicate mixtures of lymph- 
ocytes (1 X  107) and labeled target cells (5 X  104), at an attacker to target cell ratio of 200:1, 
were incubated on a rocking platform for 4 hr at 37°C, with a moist atmosphere of 90% air, 
10% carbon dioxide. The per cent cytotoxicity for each group was calculated as follows: 
cf  o Cytotoxicity  cpm 61Cr released from cells during incubation 
=  X  100. 
cpm s~Cr released from cells by three times freeze-thaw 
1 Abbreviations  used in this paper:  BSS, balanced salt solution; FBS, fetal bovine serum. MANUEL ORTIZ DE  LANDAZURI AND  RONALD B.  HERBERMAN  971 
Experimental results were expressed as: 
% Cytotoxicity in experimental group -- % cytotoxicity in control group. 
Assay for Inhibition of Cytotoxicity.--Specificity of the cytotoxic reaction was tested by an 
inhibition assay, as previously described  (14). To the usual incubation mixture of 1 X  107 
lymphocytes and 5 )< l04 51Cr-labeled (C58NT)D  target cells, 0.2 X  10  a unlabeled inhibitor 
cells were added to give a final attacker to target cell ratio of 40:1. The cytotoxicity assay 
was then performed in the usual manner. 
In Vitro Activation of Lymphocytes.--Cell suspensions were prepared from the lymphoid 
cells of rats 40 days or longer after tumor cell inoculation.  Mter washing twice with 50 ml of 
BSS-FBS, 1 X  107 cells in 1 ml of RPMI 1640 medium with 15% FBS in a 13 X  100 mm 
plastic tube were incubated for 18-24 hr at 37°C in an atmosphere of 10% carbon dioxide. 
After incubation, the cells were sedimented at 100 g for 10 min, washed once, and resuspended 
in  RPMI  1640-FBS. The  lymphocytes were  then  tested for  cytotoxic reactivity against 
~lCr-labeled (C58NT)D  cells, at the usual attacker to target cell ratio of 200:1. The concen- 
tration of attacker cells was calculated on the basis of viable cells, excluding trypan blue dye. 
Viability at the end of each of the incubation periods was 85-90%. 
RESULTS 
In  Vitro Activation of Spleen Cells from Rats 40 Days after  Tumor Inocula- 
tion.--Spleen cells obtained from rats 40 days after inoculation of (C58NT)D 
have never given positive results in the direct cytotoxicity assay. Two possible 
explanations for this unreactivity were  studied:  (a)  The presence  of 7S  anti- 
bodies or other substances in the animals had an inhibitory effect on the effec- 
tor cells. If this were the case, one might expect that spleen cells removed from 
the animal could become positive after a  period of time.  (b) At 40 days after 
tumor cell inoculation, cytotoxic cells were no longer present, perhaps because 
of lack of effective antigenic stimulation. Memory cells might then be present, 
which could be activated by exposure to antigen in the absence of circulating 
antibody (15,  16). 
To  test these possibilities, spleen cells were incubated in vitro for  24 hr  at 
37°C,  by  themselves  or  in  the  presence  of  (C58NT)D  tumor  cells  (1  X  107 
spleen  cells +  5  X  104  tumor  cells). The  cells were  then  washed  and  tested 
against 51Cr-labeled tumor cells. Table I  gives the results of a  typical experi- 
ment.  In the direct assay, without preincubation, spleen-4@ cells had no  sig- 
nificant  cytotoxic  activity whereas  spleen-10  cells  were  positive.  After  pre- 
incubation of spleen-40 cells for 24 hr,  definite cytotoxic activity was found. 
Preincubation in the presence of antigen was not needed; in fact,  the degree 
of cytotoxicity was  slightly less in  this  group.  As had  been  noted previously 
(10),  spleen-10  cells incubated  in  the  presence  of  antigen  showed  increased 
reactivity. 
It was important  to determine whether  the cytotoxic reactivity which  de- 
veloped in the spleen-40 cells had the same immunological specificity as spleen- 
2 Immune lymphoid cells are designated by the source of the cells followed by the number 
of days after tumor cell inoculation; e.g., spleen-40 indicates spleen cells obtained 40 days 
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10 ceils. When  activated spleen-40 cells were tested against LW-6,  a  spontane- 
ous W/Fu  rat leukemia, negative results were obtained  (Table II). The speci- 
ficity  was  further  tested  by  an  inhibition  assay.  Of  the  various  cells  tested, 
only  (C58NT)D  had  inhibitory  activity  (Table  II).  This was  the  same  speci- 
ficity which  had  been  previously demonstrated  for spleen-10  cells (14). 
TABLE I 
Cytotoxicity  of Spleen Cells after In Vitro Incubation for 24 hr 
Period of  % Lysis (±sE) against 
Cells in preincubation mixture  preincubation  .~lCr-labeled  (C58NT)D cells* 
h~ 
Spleen-40  0  0.5  (0.4) 
Spleen-40  -}-  (58NT)D~:  0  --0.2  (0.5) 
Spleen-40  24  9.8  (0.6) 
Spleen-40  -}-  (C58NT)D$  24  8.6  (0.4) 
Spleen-10  0  8.5  (0.3) 
Spleen-10  -b  (C58NT)D$  0  7.8  (0.4) 
Spleen-10  24  8.1  (0.4) 
Spleen-10  -b  (C58NT)D$  24  16.5  (0.8) 
Normal spleen  24  0.9  (0.5) 
Normal spleen q-  (C58NT)D~  24  1.3  (0.5) 
* Control group  =  normal spleen cells without in vitro preincubafion. 
$ At a ratio of 200:1,  1 X  107 spleen cells q- 5 X  104 tumor cells. 
TABLE  II 
Specificity  of Cytotoxic Effects of Spleen-40,  after Preincubation for 24 hr 
Direct assay  Target cell  % Lysis (±sE) 
(C58NT)D  15.2  (0.6) 
LW-6  1.0  (0.7) 
Inhibition assay  Inhibitor  ceils  % Lysis (q-sE)*  Inhibitory effect on  spleen-10 cells (14) 
20.2  (0.4) 
Rat tumors 
W/Fu (C58NT)D  7.1  (0.3)~ 
W/Fu ERTh/V-G  8.9  (0.4):~ 
W/Fu LW-6 (spontaneous leukemia)  19.4  (0.5) 
Mouse cells 
C57BL/6 spleen  18.5  (0.6) 
C57BL/6 E o~G2 (Gross  virus-induced)  18.2  (0.7) 
C57BL/6 EL-4 (chemically induced leukemia)  17.8  (1.0) 
C57BL/6 RBL-5 (Rauscher virus-induced)  17.5  (1.1) 
BALB/c LSTRA (Moloney virus-induced)  18.0  (0.8) 
+ 
+ 
* Ratio of spleen-40  cells (1 X  107) to 51Cr-labeled  (C58NT)D cells (5 >(  104) was 200:1. 
Inhibitor cells  (0.2  X  106) were added to give a final attacker  to target cell ratio of 40:1. 
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In  Vitro Activation of Other Lymphoid Cells.--It was previously found that 
cytotoxic reactivity of all of the lymphoid cells disappeared by 25 days after 
inoculation of (C58NT)D  (10).  It was  of interest to determine whether cells 
from the  various lymphoid organs  could be  activated in vitro,  in  the  same 
manner  as  spleen-40 cells.  Cells  were harvested  from the  spleen,  peripheral 
blood, lymph nodes, peritoneal cavity, and bone marrow of rats 40 days after 
inoculation with  tumor cells.  After 24 hr of preincubation at 37°C,  the cells 
were washed and tested for cytotoxic reactivity against ~Cr-labeled (C58NT)D 
cells  (Table III).  Spleen, peripheral blood, lymph node,  and peritoneal cells 
all  developed significant cytotoxic reactivity. The activity of spleen cells was 
always higher than  that of the other lymphoid cells.  Bone marrow cells did 
not become reactive. 
Studies with Lymphocytes Obtained  at  Various  Times after  Immunization.- 
Spleen cells were obtained from W/Fu rats at various times after inoculation 
TABLE III 
Cytotoxicity of Various Lymphoid Cell Populations, after In Vitro Incubation  for g4 hr 
Attacker cells*  % Lysis (::t=sr) 
Spleen  17.9  (0.6):~ 
Blood  7.4  (0.8):~ 
Lymph nodes  3.5  (0.7) :~ 
Peritoneal  4.7  (0.6)~ 
Bone marrow  1.3  (0.8) 
* Ceils harvested from  W/Fu rats, 40 days after immunization with (C58NT)D. 
2~ Results significantly  higher than controls, P  <  0.05. 
of (C58NT)D cells. Each of the cell suspensions was tested for direct cytotoxic- 
ity and  also preincubated for 24 hr  at 37°C  and  then  tested for reactivity. 
These experiments were performed several times, with similar results on each 
occasion.  None of  the  spleen  cell preparations,  from rats  immunized  25  or 
more days  earlier,  were  positive without  preincubation.  In  vitro  activation 
occurred, however, with most of the groups. The results of a  typical experi- 
ment are summarized in Table IV. Spleen cells from rats 40 or more days after 
immunization became strongly positive after preincubation. In this experiment, 
as  in  all the others performed, higher results were seen in  the  groups which 
were 60 or more days after inoculation. In some instances, at 35-40 days after 
immunization,  only low  levels of  activity developed. In  the period  between 
25  and 35  days,  no reactivity has  been seen either on immediate testing or 
after preincubation. 
Effect of Reinoculation of Tumor Cells upon Extent of In  Vitro Activation.- 
It was previously shown that reexposure to tumor cells 30-40 days after initial 
immunization  produced  no  detectable  cytotoxic  reactivity  (9).  It  was  of 
interest to determine whether a boost in cytotoxicity would become apparent 
after preincubation of spleen cells.  At  27,  35,  60,  and  100  days  after initial 974  IMMUNE  RESPONSE  TO  GROSS  VIRUS-INDUCED  LYMPHOMA 
immunization, groups of three rats were given a  second subcutaneous dose of 
1 N  108  (C58NT)D  cells. At  l0 days after  reinoculation, pooled spleen cells 
from each group were tested for immediate reactivity and for in vitro activa- 
tion. For comparison, tests were also performed with pooled spleen cells from 
TABLE IV 
Cytotoxicity of Spleen Cells from Rats at Various Times after Immunization 
Attacker cells; time after 
immunization 
%  Lysis (-+-sE) 
Immediate test  After preincubation 
days 
27  0.9  (0.5)  --0.6  (0.4) 
33  0.5  (0.6)  -0.5  (0.4) 
40  --0.4  (0.5)  13.3  (1.8)* 
60  0.7  (0.8)  21.6  (1.3)* 
80  --0.2  (0.4)  23,6  (1.5)* 
120  0.8  (0.5)  27.8  (1.0)* 
180  -0.3  (0.4)  16.7  (0.9)* 
* Results significantly higher  than controls, P  <  0.05. 
TABLE  V 
l"ffect of Reinoculatlon of Tumor Cells on In  Vitro Activation 
Attacker cells; time  Reinoculation*  c/;) Lysls (-4-sE) 
after initial 
immunization  Immediate test  After 18 hr preincubation 
days 
10  --  17.1  (0.8)  16.3  (1.7) 
37  --  --0.8  (0.6)  16.2  (0.6) 
37  +  --1.1  (0.8)  16.3  (0.5) 
45  --  --2.4  (0.7)  12.9  (0.6) 
45  +  -2.0  (0.8)  15.8  (l.0):~ 
70  --  -0.1  (1.4)  20.6  (1.2) 
70  +  0.5  (0.7)  24.7  (1.1)~c 
110  --  -1.2  (0.9)  21.2  (0.7) 
110  +  2.3  (0.8)  22.3  (0.7) 
* I0 days before assay, some rats reinoculated subcutaneously with  1 ;K  10  s (C58NT)D 
tumor cells. 
:~ Significantly higher than group not receiving second injection of tumor cells, P  <  0.05. 
animals which were not reinoculated  (Table V).  On direct testing, cytotoxic 
activity was seen only in the spleen-10 group. After  18 hr preincuba~ion, the 
spleen cells of all groups showed reactivity. In the 40 and 70 day groups, re- 
inoculation resulted in significantly higher activity. In all of the groups, rein- 
oculation of tumor cells resulted in no detectable tumor growth. This indicated 
that  in vivo immune protection persisted  for  at  least  100  days  after  initial 
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Studies to Define the Mechanism for In Vitro Activation.--Experiments were 
performed  to  determine  the  kinetics  of  activation  of  spleen-40  cells.  Cells 
were  incubated  for various  lengths  of  time  at  37°C  or  at  4°C  and  then  all 
tested  at  the  same  time  for  cytotoxic  reactivity  against  (C58NT)D  cells. 
Fig. 1 shows the results of preincubation at 37°C. A low but significant amount 
of activity appeared after 4 hr; peak reactivity was seen after 24 hr. A longer 
period  of incubation  resulted  in  a  decline  in  activity. The cells incubated  at 
4°C  remained viable but  did  not develop any detectable  activity. This indi- 
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FIG.  1.  Cytotoxic activity  of  spleen-40  cells  against  (C58NT)D  target  cells,  after  pre- 
incubation of immune cells at 37°C. 
cated  that in vitro activation is temperature dependent,  and may depend  on 
some active metabolic processes. 
One possible explanation for the  lack of immediate reactivity of spleen-40 
cells was that  an inhibitory substance was associated with  the cells.  Such  an 
inhibitor might dissociate from the cells or become inactive after in vitro in- 
cubation  at  37°C.  The  possible inhibitor  was  looked  for in  several different 
ways. 
(a) Active spleen-10 cells were diluted with increasing amounts of spleen-40 
cells  and  tested for cytotoxicity. The control was spleen-10 cells mixed with 
normal cells.  Fig. 2 shows that both curves were very similar. The presence of 
spleen-40 cells had no inhibitory effects on the activity of the spleen-10 cells. 
(b)  If an inhibitor  substance dissociated from the spleen-40 cells during in 
vitro incubation,  it  might  be detectable  in  the  supernatant  fluid.  After pre- 
incubation of spleen-40 cells for 24 hr,  they were tested either in the preincu- 976  IMMUNE  RESPONSE  TO  GROSS  VIRUS-INDUCED  LYMPHOMA 
bation medium or in fresh medium,  after washing the cells twice (experiment 
1,  Table  VI). There  was  no  significant difference between  the results. 
(c)  An  inhibitor  was  also  looked  for  by  suspending  spleen-10  cells in  the 
preincubation  medium  and  testing  for  cytotoxic  activity  (experiment  2, 
Table  VI).  No  inhibition  was  found. 
15 --  ---SPLEEN-IO/SPLEEN-NORMAL  w 
F-  -'xT'k  --  SPLEEN-IO/SPLEEN-40 
cn  10- 
m  200/0  150/50  I  175 
RATIO  OF  IO-DAY IMMUNE CELLS  TO 
NORMAL  OR  40-DAY  IMMUNE  CELLS 
FIG. 2.  Cytotoxic activity of spleen-10 cells mixed with varying proportions of normal 
spleen cells or spleen40 cells. The total number of spleen cells added to the 5 X  104 (C58NT)D 
target cells was kept constant at 1 X  107. 
"FABLE VI 
Tests for Possible Inhibitors in Preincubation Medium 
Attacking cells  Medium  used for assay  % Lysis (4-sE) 
Experiment 1 
Spleen-40, 24 hr preincubation 
"  -40, 24  .... 
Experiment 2 
Spleen-10 
"  -10 
Experiment 3 
Spleen-40, 24 hr preincubation in fresh 
medium 
Spleen-40, 24 hr preincubation in prein- 
cubation medium from an earlier 
experiment 
Fresh  12.8  (0.6) 
Spleen-40 preincubation  12.5  (0.7) 
medium 
Fresh  11.1  (0.8) 
Spleen-40 preincuba  tion  12.9  (0.8) 
medium 
Fresh  16.5  (0.4) 
Fresh  15.9  (0.7) 
(d)  Spleen-40 cells were  incubated  for  24  hr  at  37°C  in  the  preincubation 
medium of a previous experiment and then tested for cytotoxicity. This might 
be  expected to subject the cells to  a  higher  concentration  of inhibitor. How- 
ever,  this  did  not  result  in  a  significant  decrease  in  activity  (experiment  3, 
Table VI). 
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it  might  be  possible  to  remove  it  by  trypsin  digestion  and  thereby  rapidly 
activate the cells. Spleen-40 cells were incubated for 30 min at 37°C with 0.25 % 
crude  trypsin  or with  0.1%  crystalline trypsin.  The  cells were  then  washed 
and tested for cytotoxic activity. Negative results were  obtained. 
Direct cellular reactivity declines and becomes undetectable  at the time of 
TABLE VII 
Effect of Rat Serum on In Vitro Activation* 
Serum in preincubation medium  % Lysis (:hSE) 
Experiment 1 
25% FBS  16.4  (1.3) 
25% normal rat serum  (NRS)  4.9  (0.8) 
25% immune serum, peak I:~  --1.4  (1.0)§ 
250-/0 immune serum, peak II[]  --0.6  (1.1)§ 
Experiment 2 
25% FBS  14.4  (0.7) 
25% NRS  4.5  (0.4) 
25% immune serum, peak I  0.5  (0.3)§ 
25% immune serum, peak II  --0.5  (0.7)§ 
Experiment 3 
15% FBS  23.7  (1.5) 
15%NRS  17.1  (0.7) 
5%NRS, 10%FBS  21.1  (1.1) 
1% NRS, 14% FBS  21.7  (1.0) 
15% peak II  14.2  (1.2) 
5% peak II, 10% FBS  16.8  (0.8)§ 
1% peak II, 14% FBS  17.0  (1.5)§ 
* Spleen-40 cells suspended  in medium containing FBS or rat serum at various concen- 
trations were preincubated at 37°C for 24 hr, washed  once, and tested for cytotoxicity. As 
controls for each group, normal spleen cells were incubated in medium containing the same 
type and concentration of serum. 
:~ Pooled serum from rats, 10-14 days after subcutaneous inoculation of 1 X  l0 s (C58NT)D 
cells. Cytotoxic antibody titer of serum was 60. 
§ Activity significantly lower, P  <  0.05, than that seen with normal rat serum at same 
concentration. 
II Pooled serum from rats, 30--40 days after subcutaneous inoculation of 1 X  108 (C58NT)D 
cells. Cytotoxic antibody titer of serum was 160. 
appearance  of  7S  antibodies  (9).  It  seemed  quite  likely that  the  antibodies 
had  an  inhibitory influence  on  the  immune  lymphocytes.  Incubation  of  the 
cells for a  period of time in vitro,  away from the influence of the antibodies, 
might  allow them to become  activated. The most direct way to test this hy- 
pothesis  was  to  perform  the  in  vitro  incubation  in  the  presence  of  rat  sera 
containing 7S antibody (peak II) or 19S antibody (peak I  serum). The results 
of three representative experiments are given in Table VII.  None  of the  ex- 
periments  gave  clear-cut  results.  Complete  inhibition  of  activation occurred 978  IMI~IUNE  RESPONSE  TO  GROSS  VIRUS-INDUCED  LYMPHOMA 
only when high concentrations of serum  (25 cA) were used. At that level, nor- 
real rat serum  also had  inhibitory activity. There was, however,  a  significant 
difference between the effects of immune sera and of the normal sera. At lower 
concentrations  of  immune  sera,  only  partial  inhibition  was  seen  and  there 
were  only  small  differences  from  the  normal  rat  serum. 
Effects  of Separation  of Lymphocytes  on  In  Vitro  Activation.--Experiments 
were performed  to  determine  the nature  of  the cells involved in  the  in vitro 
TABLE VIII 
Effect of Lymphocyte  Purification  Techniques on In Vitro Activation 
Attacker cells* 
% Lysis (:kSE) 
No purification 
Purification  on nylon column  Purification  on 
Ficoll-Hypaque 
Before  After  gradient before 
preincubation  preincubation  preincubation 
Spleen-40  6.5  (0.4)  1.0  (0.5)  5.7  (0.8) 
Spleen-40  13.3  (1.8)  1.9  (1.2)  14.7  (1.1)  15.2  (0.9) 
Spleen-40  11.8  (0.6)  0.7  (0.3)  13.0  (0.5) 
Spleen-80  23.6  (1.5)  0.7  (1.5)  22.5  (0.7)  25.4  (0.9) 
Spleen 150  12.0  (1.4)  0.5  (1.0)  9.2  (0.9) 
* As controls for each group, normal spleen cells were manipulated in the same manner. 
TABLE IX 
Effect of X-Irradiation on In  Vitro Activation 
Treatment of attacker cells*  % Lysis  (±sE) 
No radiation  6.6  (0.3) 
500 R, before preincubation  6.7  (0.4) 
1000 R,  "  "  1.2  (0.4) 
3000 R,  ' ....  0.6  (0.2) 
500 R, after preincubation  7.1  (0.9) 
1000 R,  "  "  8.1  (0.8) 
3000 R,  "  "  7.3  (0.9) 
* Spleen-40 ceils preincubated at 37°C for 18 hr and then tested for cytotoxicity. 
activation. Spleen-40 cells were passed through a  nvlon wool column  and then 
incubated  for  24  hr  at  37°C.  No  cytotoxic  activity was  detectable  in  these 
cells  (Table  VIII).  Several  repeat  experiments  were  performed,  confirming 
these results. In contrast, lymphocytes isolated by centrifugation on  a  Ficoll- 
Hypaque  gradient  showed  good in vitro  activation.  These  experiments  indi- 
cated that a  cell type necessary for activation was removed by the nylon col- 
umn.  Experiments were then performed, to determine if, after in vitro activa- 
tion, reactivity could still be removed by the nylon. No decrease in cytotoxicity 
was seen (Table VIII). As was previously found with spleen-10 cells (10), these 
experiments indicate  that  most  active  attacker cells do  not  adhere  to  nylon 
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It seemed possible that normal phagocytic cells might be needed for activa- 
tion to occur. Experiments were therefore performed in which equal numbers 
of column-separated  spleen-40 cells  and normal  spleen cells were mixed.  In- 
cubation  of these mixtures for 24 hr resulted in no  appearance  of cytotoxic 
activity. 
Effect of X-Irradiation on In Vitro Activation.--To further define the charac- 
teristics of the cells involved in  activation,  the  effects of X-irradiation were 
studied. When cells were exposed to 500 R  before in vitro incubation, no in- 
hibitory  effect was  seen  (Table  IX).  Higher  levels  of  radiation  reduced  or 
eliminated the appearance of cytotoxicity. When the cells were radiated with 
as much as 3000 R  after activation, no inhibitory effects were observed. 
DISCUSSION 
Evidence has been presented here for some form of central inhibition of im- 
mune cell activity. Lymphoid cells from rats, 20 or more days after immuniza- 
tion, did not have any detectable direct cytotoxic activity. Incubation of these 
cells outside of the host's environment for 12-24 hr resulted in the appearance 
of  considerable  activity.  The  activated  cells  had  the  same  immunological 
specificity as  that  observed with  spleen-10  cells  (14). 
These findings are reminiscent of the study of McGregor et al.  (17). They 
found that in vitro incubation of thoracic duct ]ymphocytes from rats tolerant 
to sheep erythrocytes resulted in their ability to produce hemolysin. However, 
they noted that a  similar procedure failed to "break tolerance" to transplan- 
tation antigen. 
Canty et al.  (16)  have observed a similar activation phenomenon with the 
cytotoxic reactivity  to  mouse  alloantigens.  Spleen  cells  from hyperimmune 
animals  became much  more reactive after  transfer  to  sublethally irradiated 
syngeneic hosts.  They postulated  that  the  presence of humoral  antibody in 
the intrasplenic environment of the primary hosts had a suppressive effect on 
immune  cell  activity.  An  important  difference from  the  present  study  was 
that the increased activity only occurred when the immune spleen cells were 
administered  to  the  secondary host  along with  antigen. 
In  the present  study, we pelformed a  variety of experiments to  elucidate 
the mechanism for the in vitro activation. Removal of the immune cells from 
inhibitory substances was thought to be an important factor. Amos et al.  (7) 
have postulated that a soluble inhibitor substance is the mediator of immuno- 
logical enhancement. However, we found no evidence for an inhibitory activity 
in the spleen-40 cells o~  for release of an inhibitor into the supernatant fluid 
during  the preincubation period. The possible  role of humoral  antibody was 
not  clearly determined  and  the  observed phenomena may  therefore be  dif- 
ferent from classical immunological enhancement. The 7S cytotoxic antibody, 
which is present in vivo at the time of disappearance of direct cellular cyto- 
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obtained from rats at the time of maximal direct cellular reactivity, had similar 
effects.  Even  normal  rat  serum had  some suppressive  activity. 
The  experimental  observations which  seemed  to provide  the  most insight 
into  the  mechanism  of  activation  were  the  effects  of  temperature  and  cell 
separation. The  appearance of activity upon incubation  in vitro occurred  at 
37°C but not at 4°C. This indicated  that simple removal of the ceils from the 
most environment was not sufficient, but rather that some active change had 
to occur in  the lymphocytes. Sensitization  or  stimulation of lymphocytes by 
antigen  carried  over in  the  spleen  cell  suspension  seems  unlikely,  however, 
because  of  the  short  time  period  needed  for  activation. 
The activation process also had a requirement for cells which  adhered to a 
nylon column. Once activation occurred, however, adherent cells were no longer 
needed.  This could be accounted for in different ways. 
(a)  The  immune cells might have been  initially  adherent,  and  during  the 
period  of  incubation,  the  surface  characteristics  changed  and  they  became 
less  adherent.  Active spleen-10 and  spleen-40 cells did  not  appear to  adhere 
significantly to the nylon. It is known that lymphoid cells can adhere to nylon 
or  glass,  but  these  cells  have generally  been  characterized  as  bone marrow- 
derived  lymphocytes  (18).  It  is  thought  that  thymus-derived  lynlphocytes 
are usually responsible for direct cytotoxic reactivity (19).  However, the dis- 
tinction  between  adherence  of  bone  marrow-  and  thymus-derived  lympho- 
cytes does not appear to be absolute. It was recently reported that some thy- 
mus-derived cytotoxic peritoneal lymphocytes were adherent (20). In addition, 
the type of lymphocyte responsible for cytotoxicity in the present system or in 
other  tumor-specific  systems has  not  been  clearly  demonstrated. 
(b) An adherent helper cell may be needed for in vitro activation. There are 
some studies which  indicate that helper cells play a  role in cell-mediated im- 
munity as well as in humoral immunity (21-23). Grant et al. (23) have repotted 
that  adherent  normal  bone marrow cells,  after exposure  to  immune  thymus 
cells plus antigen, were able to inhibit the growth of an allogeneic tumor cell. 
A  nonspecific  helper  activity of phagocytic  cells  is not  a  likely explanation, 
however,  for  the  present  observations,  since  the  addition  of  normal  spleen 
cells to the column-purified immune cells,  before incubation for 24 hr, did not 
result in activation. 
Another  possible explanation  for the  activation  phenomenon  is  that  there 
may be an  adherent  cell in  the immune lymphoid population  which  inhibits 
activation of effector cells. During  the period  of preincubation,  the  putative 
inhibitory cell may become inactive or die.  Gowans (24)  observed that,  after 
in  vitro  incubation  of  thoracic  duct  lymphocytes  for  24  hr  at  37°C,  most 
large lymphocytes died and over-all viability decreased to 78 % or less. In our 
studies,  however,  viability  of  the  lymphocytes  after  incubation  was  always 
85 %  or greater,  and there was no appreciable loss of large lymphocytes. The 
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aftei nylon column separation. If an inhibitor cell was removed by the column, 
this should have resulted in increased activity rather than less. Experiments 
are now in progress to further characterize the cells involved in the activation 
process, in  an  attempt to distinguish  among these possible mechanisms. 
Any postulated mechanism for the in vitro activation would have to account 
for lack of activation of cells from rats 25-35 days after immunization. Also, 
the reasons for the differences in the activation of the various lymphoid cell 
populations need to be explained. These might be due to the number of poten- 
tial  effector cells in  the different sites,  or to the proportion of helper or in- 
hibitor cells. 
The occurrence of in vitro activation could explain many of the  apparent 
differences among the various in vitro assays for cell-mediated cytotoxicity. 
The HellstrSms  (2), using a  colony inhibition technique, have found cellular 
reactivity at various stages of tumor involvement and after tumor regression. 
In  the colony inhibition  assay,  lymphocytes are incubated  in vitro at 37°C 
for several days, an ample period for activation to occur. In comparative studies 
of reactivity against  the  rat  Gross lymphoma with  the present  cytotoxicity 
assay  and  the microcytotoxicity assay  as  used  by  the  Hellstr6ms,  we have 
indeed found that the differences in results could be accounted for by the ac- 
tivation phenomenon  (Wright,  Ortiz de Landazuri,  and Herberman, unpub- 
lished observations). The results of Denham et al. (15) could also be explained 
in the same way. The characteristics of their 21-day spleen cells were quite 
similar to those of our spleen-40 cells. 
SUMMARY 
Spleen cells from W/Fu  rats  40  days or more after immunization with  a 
syngeneic Gross  virus-induced  leukemia were  unreactive in  direct cytotoxic 
assays. Incubation of these immune cells at 37°C  for 12 hr or longer, in the 
absence of antigen, resulted in the appearance of specific cytotoxic reactivity. 
Other lymphoid cells from the immune rats also were activated upon in vitro 
incubation, but to a lesser extent. Experiments were performed to define the 
necessary conditions and the mechanism for the in vitro incubation. Activa- 
tion was temperature dependent, occurring at 37°C but not at 4°C.  Immune 
serum  suppressed  the  activation,  but  normal  rat  serum  also  had  some  in- 
hibitory activity.  Passage  of immune  cells  through  a  nylon column,  before 
preincubation,  prevented  activation.  In  contrast,  exposure  to  nylon  after 
preincubation  did  not  remove  cytotoxic reactivity.  These  findings  demon- 
strate the reversal of a central inhibition of immune cell activity. The explana- 
tions  offered for this phenomenon included change in surface characteristics 
of the immune cells during in vitro incubation,  and the possible need for an 
adherent helper cell. 
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